France Industrial Air Compressor Market Size 2024: Global Share, Industry And Report Analysis By 2031 | Airman Asia Sdn Bhd (Hokuetsu Industries Co., Ltd.) Atlas Copco AB BAUER COMPRESSORS INC. 12-28-2024 11:10 AM CET | Business, Economy, Finances, Banking & Insurance Press release from: orion market research France Industrial Air Compressor Market France industrial air compressor market is estimated to grow considerably, at a CAGR of around 4.2% during the forecast period. This informative France Industrial Air Compressor Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this France Industrial Air Compressor Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help of this France Industrial Air Compressor Market study report. Get Free Sample link @ https://www.omrglobal.com/request-sample/france-industrial-air-compressor-market France industrial air compressor market is segmented based on type, technology, and end-user. Based on the technology, the market is classified into dynamic displacement and positive displacement compressors. The dynamic displacement compressors segment is further segmented into axial flow air compressors and centrifugal compressors. Whereas the positive displacement compressors segment is further segmented into rotary air compressors and reciprocating compressors. Furthermore, rotatory compressors include lobe, screw, liquid ring, scroll & vane compressors while reciprocating includes diaphragm double-acting and single-acting compressors. Based on type, the market is classified into portable and stationary. Based on end-user, the market is segmented into food and beverage, oil and gas, manufacturing, energy & power, automotive, and others. A full report of France Industrial Air Compressor Market available @ https://www.omrglobal.com/industry-reports/france-industrial-air-compressor-market •Market Coverage •Market number available for - 2024-2031 •Base year- 2024 •Forecast period- 2024-2031 •Segment Covered- By Source, By Product Type, By Applications •Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others Market Segmentation France Industrial Air Compressor Market by Type oPortable oStationary France Industrial Air Compressor Market by Technology oDynamic Displacement Compressors oAxial Flow Air Compressors oCentrifugal Compressors oPositive Displacement Compressors oRotary Air Compressors oReciprocating Compressors France Industrial Air Compressor Market by End-Users oFood & Beverages oOil & Gas oEnergy and Power oManufacturing oAutomotive oOthers (Construction and Mining) Company Profiles oAtlas Copco AB oBAUER COMPRESSORS INC. oBOGE Anlagenbau GmbH & Co. KG oELGi Compressors s.r.l. oGeneral Electric Co. oHitachi Ltd. oIngersoll-Rand PLC oJ.P. Sauer & Sohn Maschinenbau GmbH oMattei MATTEI COMPRESSORS, INC. oSiemens AG The Report Covers •Comprehensive research methodology of the France industrial air compressor market. •This report also includes a detailed and extensive market overview with key analyst insights. •An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. •Analysis of regional regulations and other government policies impacting the France industrial air compressor market. •Insights about market determinants which are stimulating the France industrial air compressor market. •Detailed and extensive market segments with regional distribution of forecasted revenues. •Extensive profiles and recent developments of market players. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/france-industrial-air-compressor-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404 This release was published on openPR.Pep Guardiola admits he is questioning himself after Man City lose to Juventus
Bills defense out to prove against high-scoring Lions that it's better than its dud vs. RamsORLANDO, Fla. , Dec. 16, 2024 /PRNewswire/ -- The 2025 AIUM Annual Convention , hosted by the American Institute of Ultrasound in Medicine (AIUM), will explore the cutting edge of medical technology through keynote presentations on space exploration, medical innovation, and neurotherapeutics. Taking place from March 29 to April 1 in Orlando, Florida , the 2025 Ultrasound Event will showcase groundbreaking developments in ultrasound technology and its expanding role in space medicine and advancements in brain health, like treating addiction, Parkinson's disease, and Alzheimer's disease. "With leaders like Dr. Chiao, Dr. Dulchavsky, and Dr. Rezai guiding our keynote sessions, we are not just imagining the future of ultrasound; we are helping create it," said Richard A. Hoppmann , MD, FACP, FAIUM, President of the AIUM. "The work of our speakers reflects the commitment to progress that defines our field, and opens new avenues for improving patient care." Dr. Leroy Chiao , PhD , a former National Aeronautics and Space Administration (NASA) astronaut and International Space Station commander, will kick off the event with his keynote presentation, "Is It SADS, or Am I in Space? Medical Considerations for Spaceflight" . Drawing on his personal experiences in space, Dr. Chiao will explore the physiological effects of space environments and the development of countermeasures and diagnostics for space missions. He will also highlight how advancements in space medicine contribute to healthcare solutions on Earth. Dr. Chiao was one of the first astronauts to use ultrasound in space. "From understanding space-related medical conditions to adapting ultrasound technologies for use in space, we continue to learn and innovate in ways that enhance healthcare for all," said Dr. Chiao. Scott Dulchavsky , MD, PhD , a NASA principal investigator and Surgeon in Chief at Henry Ford Health, will follow with his keynote, "Extraterrestrial Medical Care." Dr. Dulchavsky will explore how ultrasound has become an essential tool in diagnosing a wide range of conditions during manned space missions and how these lessons translate into groundbreaking advancements in healthcare on Earth. "Ultrasound has proven to be an invaluable tool in space medicine," said Dr. Dulchavsky. "What we have learned in space is already transforming medical care back on Earth." Ali R. Rezai , MD , Executive Chair and Director of the WVU Rockefeller Neuroscience Institute, will present "Focused Ultrasound: Breaking Barriers in Neurotherapeutics." Dr. Rezai will discuss the groundbreaking potential of focused ultrasound in treating neurological conditions such as Alzheimer's, Parkinson's, and addiction, offering new hope through non-invasive treatments. "Focused ultrasound has the power to revolutionize how we treat neurological disorders," Dr. Rezai stated. "I look forward to sharing the advancements we are making in brain health and demonstrating how ultrasound technology is leading the way to more effective, less invasive treatments." The 2025 Ultrasound Event invites attendees to Orlando for in-depth discussions on the latest breakthroughs in medical technologies, setting the stage for the evolution of medical ultrasound. Convention topics will cover obstetric ultrasound, gynecologic ultrasound, musculoskeletal ultrasound, point-of-care ultrasound (POCUS), artificial intelligence (AI) in ultrasound, and many more. For registration and more information about The Ultrasound Event 2025, please visit the event's website . If you're interested in partnering with or sponsoring the event, follow this link . About the AIUM The American Institute of Ultrasound in Medicine (AIUM) is a multidisciplinary medical association of more than 7,000 physicians, sonographers, radiologists, scientists, students, and other healthcare professionals. With over 70 years of experience, the AIUM is dedicated to empowering and cultivating a global multidisciplinary community engaged in the use of medical ultrasound through raising awareness, education, sharing information, and research. Learn more about the AIUM's membership , AIUM's Journal of Medical Ultrasound , AIUM Accreditation , and educational offerings . View original content to download multimedia: https://www.prnewswire.com/news-releases/exploring-space-and-neurotherapeutics-at-the-2025-ultrasound-event-a-journey-into-the-future-of-medical-ultrasound-302332900.html SOURCE American Institute of Ultrasound in Medicine (AIUM)Curt Cignetti Doesn’t Hesitate When Asked About Indiana’s College Football Playoff Hopes
Tech stocks extended their rally to new heights on Monday, with the Nasdaq 100 index climbing over 1% to surpass 22,000 points, fueled by robust gains among key components in the index. Broadcom Inc. AVGO led the charge, soaring over 8% after receiving bullish price-target updates from analysts. The company's AI-driven growth potential gained further traction on Friday following its announcement of a collaboration with Apple Inc. AAPL to produce a cutting-edge AI chip. Tesla Inc. TSLA also rallied, jumping more than 5%, pushing its post-election gains to 85%, buoyed by positive analyst sentiment. Wedbush Securities described Tesla as a “game-changer” in AI and autonomous advancements under Trump's administration, adding to the bullish outlook. Among other indices, the Russell 2000 rose 1%, while the S&P 500 edged up 0.4%. The Dow Jones Industrial Average, however, dipped 0.2%, weighed down by losses in the energy and healthcare sectors. On the economic front, private-sector surveys showed a stronger-than-expected rebound in December activity. The services sector Purchasing Managers’ Index (PMI) surged to 58.5, the highest reading since October 2021. Meanwhile, the Composite PMI climbed to 56.6, its best level since April 2022, as robust growth in services offset continued weakness in manufacturing. Crypto-related assets gained fresh bullish momentum, driven by speculation about the U.S. government creating a Bitcoin Strategic Reserve fund. Meanwhile, MicroStrategy Inc. MSTR will be added to the Nasdaq 100 Index on Dec. 23, further boosting sentiment. Bitcoin BTC/USD reached $107,000, marking a year-to-date gain of 153%. MicroStrategy shares rose 5.8%, while other crypto-linked stocks, such as MARA Digital Holdings Inc. MARA , Riot Platforms Inc. RIOT , and Coinbase Inc. COIN , surged 11.1%, 9.2%, and 4.5%, respectively. Monday’s Performance In Major US Indices, ETFs Major Indices Price 1-day % Nasdaq 100 22,043.82 1.2% Russell 2000 2,369.39 1.0% S&P 500 6,076.94 0.4% Dow Jones 43,750.42 -0.2% According to Benzinga Pro data: The SPDR S&P 500 ETF Trust SPY rose 0.5% to $607.34. The SPDR Dow Jones Industrial Average DIA eased 0.2% to $438.86. The tech-heavy Invesco QQQ Trust Series QQQ rose 1.4% to $537.94. The iShares Russell 2000 ETF IWM rose 1% to $235.13. The Consumer Discretionary Select Sector SPDR Fund XLY outperformed, up by 1.2%; the Energy Select Sector SPDR Fund XLE lagged, down 1.8%. Monday’s Stock Movers Micron Technology Inc. MU rose 7.1%, reflecting bullish investor sentiment ahead of its earnings report on Wednesday after the close. Alphabet Inc. GOOGL rose by 4.7%, building up momentum after last week’s 8.7% surge following the announcement of the quantum computer launch. Shares of of natural gas companies fell amid prospects for less colder weather in the upcoming weeks. New Fortress Energy Inc. NFE led industry declines, down 7%. Read Next: Fed Poised To Cut Interest Rates By 0.25% This Week: Here’s Why Your Focus Should Shift To Other Signals Photo: Shutterstock © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Bills defense out to prove against high-scoring Lions that it's better than its dud vs. Rams
Beyoncé starts new NFL traditionExpressing serious concern over some farmers leaders not allowing Jagjit Singh Dallewal — who is on ‘fast unto death’ in support of the demand for legally guaranteed minimum support price for crops — to be shifted to hospital in the wake of his deteriorating health condition, the Supreme court on Saturday also expressed dissatisfaction with the efforts made by the Punjab government in persuading the fasting farmer leader to agree to medical aid and hospitalisation. “Please communicate to them (agitating farmers leaders) that those who are resisting Dallewal’s hospitalisation are not his well-wishers,” a vacation bench of Justices Surya Kant and Sudhanshu Dhulia said and on an assurance by the Punjab, Chief Secretary, Director General of Police and the Advocate General Gurminder Singh, granted more time to take appropriate steps to comply with its December 20, 2024, directions. Advertisement The Chief Secretary, and the Director General of Police of Punjab appeared in the hearing through video-conferencing. Advertisement The top court on December 20, 2024, had directed the Punjab government to provide medical aid to Dallewal and to convince him to go to the hospital. Taking exception to the Punjab government’s argument that the state was “helpless and saddled” as other protesting farmers were obstructing its attempts to secure medical aid to Dallewal, Justice Surya Kant said, “If state machinery says you are helpless, then do you know what is the repercussion? You are a constitutionally elected government... Court is not saying to use unwanted force.” The top court today questioned the Central government, asking what it was doing to diffuse the situation. Justice Dhulia said that even a word from the Union (Central government) can help diffuse the situation. He said the Punjab government that if it requires any assistance, the Central government would give all requisite support to ensure compliance of the court’s directions. As Advocate General Gurminder Singh told the bench that “Farmers are keeping close vigil around the protest site. If a move is made to take him somewhere, then...”, Justice Surya Kant said, “So long the gathering is there for the purpose of the demands raised by farmers, it is understandable. That is peaceful agitation for the purpose of raising their demands, and voice in a democratic manner... But gathering of farmers to prevent a person from being shifted to the hospital, who requires immediate medical aid, is something which is completely unheard of.” Justice Dhulia said, “This is actually abetment to suicide... You first create a problem and then take a plea, now that there is a problem we cannot do anything.” In the course of the hearing, the Chief Secretary and Director General of Police told the bench that if the evacuation of Dallewal is not peaceful considering that the farmers are resisting his shifting, there would be “collateral damage”. “If there is resistance to a lawful action, you will have to face it and meet it with whatever the law enforcement agencies do normally... What appears to be the scenario is that Dallewal is refusing despite the fact that his health is not supporting him... He appears to be under peer pressure,” Justice Kant said. “There are some farmers leaders, we don’t want to comment on their conduct. What kind of leaders are they if they are allowing him to die there? Please try to read in between the lines. Who are these people? Are they interested in Dallewal’s life or do they want him to die there at the spot? Their intention is questionable. We don’t want to comment on what kind of conduct they are exhibiting... Even if you shift him to the hospital, you can assure Dallewal that you will not allow him to break his fast. A person with medical aid can also continue that,” said the bench. Jagjit Singh Dallewal is the convenor of the Samyukta Kisan Morcha (Non-Political) and is on fast-unto-death at the Khanauri border since November 26, 2024, in support of farmers’ demands, in particular a legal guarantee of minimum support price (MSP) for crops. Having given the Punjab government a breather of four days to comply with its December 20, direction to provide medical aid to Dallewal and shift him to the hospital, the court posted the matter for further hearing on December 31, 2024. AdvertisementOn Wednesday, at Sednaya, a political prison in Syria, hundreds of people prowled the grounds. It was the third day after an astonishing rebel offensive deposed Bashar al-Assad, who had ruled as a tyrant during thirteen years of vicious civil war. After the rebels swept into Damascus, the jailers had fled Sednaya, and the prisoners had been set free. The visitors on Wednesday were relatives of men who were known to have been held there but had not reappeared. On the grass outside, burned black in places by recent fires, groups of them camped out in a grim limbo. That morning, a Turkish search-and-rescue team in blue coveralls was busy with shovels inside the darkened administration block, working at a small rectangle of dirt where a concrete slab had been torn away. Rumors persisted that there was a buried hatchway to a “red prison”—a secret underground facility where hundreds, or even thousands, of prisoners might still be alive but dying of hunger, thirst, or asphyxiation. Whether or not the rumors were true, most everyone at Sednaya seemed to believe them, and several relatives approached me to ask whether, as “a Westerner,” I could provide the technology to peer through the floors. The leader of the Turkish team told me that his group had nothing but shovels. “We are here because we want to show solidarity,” he explained, gesturing at the desperate people around him. Being entombed alive is an apt metaphor for a populace that had its civic freedoms squashed by the Assad dynasty for half a century. Hafez al-Assad, a secular nationalist from the minority Alawite sect, ran Syria tyrannically from 1971 until his death, in 2000. He was succeeded by his son Bashar, a former ophthalmologist who proved no less repressive than his father. The civil war erupted in 2011, after Bashar responded to a peaceful demonstration with deadly force. Since then, it has been estimated that six hundred thousand Syrians have been killed; some six million, nearly a third of the population, have fled into exile. Throughout the decades of the Assads’ rule, resistance of any kind was brutally quashed, and offenders were detained and tortured in a network of dozens of facilities across the country. Sednaya was the most infamous. Built in the late eighties, on a barren limestone hilltop forty minutes from downtown Damascus, it acquired such a fearsome reputation that many Syrians refused to utter its name aloud. In the first days of the war, I visited the hills nearby and spotted the complex. When I asked my driver what it was, he shook his head. Asked again, he whispered, “Sednaya” but would add only that it was a “terrible” place. Since then, as the war intensified, the prison became, by all accounts, even more terrible. In 2021, the Syrian Observatory for Human Rights calculated that as many as thirty thousand people had been executed there since the war began. But the number of people who survived within the prison’s walls was, like most everything else about it, impossible to know. When Sednaya was liberated, last weekend, some of those freed had been there for decades. One inmate had reportedly been imprisoned since 1981; he had entered as a young man of twenty-seven and emerged, a ghastly Rip Van Winkle, at seventy. The searchers who gathered on Wednesday morning, moving through dank stairwells and across the flat prison roof, were traversing a place that they could have seen only in their horrified imaginations. A militiaman in camouflage played me a cell-phone video—sent, he claimed, by a former jailer—that purportedly showed the layout of the prison and of a set of tunnels. The militiaman held out his hands uncertainly; even with the video, no one could find the tunnels. No one had even found a registry of prisoners who had been held there. I met an elderly couple from Aleppo—a man in a red-and-white-checked kaffiyeh and a woman in a dark hijab. “Where are the lists?” the man asked, and then answered himself: “There are no lists.” Moving away, he said, “All I want to know is if they are alive or dead.” For the family members who have come to Sednaya—after enduring years with no news about their fathers, brothers, sons, and nephews—any bit of evidence stirs a despairing hope, which shows plainly in their body language and on their faces. The crowd that gathered around the Turks shovelling at the floor resembled relatives of people buried in earthquakes; they watched avidly, helplessly, for any indication of life. Other visitors wandered through cellblocks, some stooping to examine the documents on prison stationery that lay everywhere. I asked one dazed-looking man about a paper in his hands. Studying it as if for the first time, he said that it had to do with food allocation—not for the prisoners but for the guards. “It says the guards have been transferred, so they don’t need the food anymore,” he said. Another visitor thrust his phone in my face. It was playing a video of a young man in shorts being beaten in a cell at Sednaya. There were vicious red welts on his body; he whimpered in fear and pain as guards struck him. For years, as reports of atrocities filtered out, Bashar al-Assad remained in power, propped up by Russian and Iranian allies. As I entered one hallway, a woman in a robe began shouting, “Now you come to look. Why didn’t you come before? Why didn’t you believe us? Why didn’t you hear us when we said they were killing us!” After a moment, she moved on, but a nearby man began shouting, too. He wanted revenge, nothing less or more. He would get a weapon and kill the Alawites—Assad’s sect, which some members of Syria’s Sunni majority see as complicit in his repression. The man vowed to kill every man, every woman, and every child he saw. A boy in a turban stood inside the barred steel door of a cell. He was looking for his brother, who had been taken, at the age of fifteen, from their family’s home in the northeastern city of Deir ez Zor. He had been gone for nine years, which would make him twenty-four now, the boy calculated. The cell floor, like all the others, was covered with unidentifiable stains and strewn with grimy gray blankets and bits of clothing. The boy looked intently at the refuse, as if expecting to see something that would help him find his brother. Up on the roof, three men pointed at a reinforced hatchway, from which a pipe protruded. Perhaps, they suggested, it was an air vent to the secret underground prison. There was a rank smell seeping from it, but it seemed like the stench of sewage, not of bodies. As I prepared to climb back down into the prison through a hole bashed through the concrete, they called out again, pointing to a hatch at the far end of the roof. Another vent there had an even worse smell—but that, too, seemed like nothing more than waste. The men went on, aimlessly looking for whatever they could find. Everywhere I went in Sednaya, it was the same story. The Syrian people had been so terrorized and disenfranchised, so thoroughly cut off from their missing relatives, that they were reduced to a kind of ad-hoc forensic anthropology. One man, who had lost two brothers and three cousins to Sednaya, told me that he had been able to visit them once, back in 2016. But he was told afterward that he could not return, and since then there had been only silence. I asked if he had tried to come back, despite the order, to check on his family members. He replied, with a stricken look, “My relatives told me not to ask about them, that it could be bad for them, and so I stopped.” As I walked down a stairwell, a young man beckoned to me, cupping his other hand over his mouth and nose. A friend of his had made a hole in the wall about six feet up and was crouched in the opening. “Please smell,” the young man asked me. This time, I thought, it did possibly smell like death. The man in the hole began tearing at the masonry and hurling aside debris. A knot of onlookers gathered, looking up through the bars of a locked doorway below. For the moment, their faces were hopeful. ♦ New Yorker Favorites A man was murdered in cold blood and you’re laughing ? The best albums of 2024. Little treats galore: a holiday gift guide . How Maria Callas lost her voice . An objectively objectionable grammatical pet peeve . What happened when the Hallmark Channel “ leaned into Christmas .” Sign up for our daily newsletter to receive the best stories from The New Yorker .
Henley High students are finalists in Solve for Tomorrow contestJPMorgan Chase & Co. decreased its stake in Kenvue Inc. ( NYSE:KVUE – Free Report ) by 54.4% during the third quarter, Holdings Channel.com reports. The institutional investor owned 29,452,952 shares of the company’s stock after selling 35,141,362 shares during the quarter. JPMorgan Chase & Co.’s holdings in Kenvue were worth $681,247,000 at the end of the most recent reporting period. Other institutional investors and hedge funds have also recently made changes to their positions in the company. Huntington National Bank lifted its stake in Kenvue by 26.5% during the third quarter. Huntington National Bank now owns 4,161 shares of the company’s stock worth $96,000 after purchasing an additional 871 shares during the last quarter. ING Groep NV raised its holdings in shares of Kenvue by 23.6% during the 3rd quarter. ING Groep NV now owns 3,576,616 shares of the company’s stock valued at $82,727,000 after buying an additional 681,954 shares in the last quarter. Kennon Green & Company LLC lifted its position in Kenvue by 140.7% in the 2nd quarter. Kennon Green & Company LLC now owns 159,106 shares of the company’s stock worth $2,893,000 after buying an additional 93,008 shares during the last quarter. Crestwood Advisors Group LLC boosted its stake in Kenvue by 14.8% in the second quarter. Crestwood Advisors Group LLC now owns 1,537,348 shares of the company’s stock worth $27,950,000 after buying an additional 198,607 shares in the last quarter. Finally, Saturna Capital Corp grew its position in Kenvue by 29.9% during the third quarter. Saturna Capital Corp now owns 1,334,860 shares of the company’s stock valued at $30,875,000 after acquiring an additional 307,039 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock. Wall Street Analysts Forecast Growth KVUE has been the topic of several recent research reports. Bank of America increased their target price on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. JPMorgan Chase & Co. lifted their price objective on Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Piper Sandler increased their target price on Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday, September 23rd. Royal Bank of Canada raised Kenvue from a “hold” rating to a “moderate buy” rating in a research note on Monday, December 9th. Finally, Deutsche Bank Aktiengesellschaft lowered Kenvue from a “buy” rating to a “hold” rating and dropped their price objective for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $22.64. Kenvue Stock Performance Shares of KVUE stock opened at $21.53 on Friday. The company’s fifty day moving average price is $22.96 and its 200-day moving average price is $21.38. The stock has a market cap of $41.28 billion, a PE ratio of 39.15, a price-to-earnings-growth ratio of 2.02 and a beta of 1.36. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46. Kenvue ( NYSE:KVUE – Get Free Report ) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The business had revenue of $3.90 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter in the previous year, the business earned $0.31 earnings per share. The firm’s quarterly revenue was down .4% compared to the same quarter last year. On average, equities analysts expect that Kenvue Inc. will post 1.07 EPS for the current fiscal year. Kenvue Announces Dividend The company also recently announced a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th were issued a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.81%. Kenvue’s dividend payout ratio (DPR) is presently 149.09%. Kenvue Company Profile ( Free Report ) Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Featured Articles Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. ( NYSE:KVUE – Free Report ). Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter .
The US tech giant said it now supported 550,000 jobs in the UK (James Manning/PA) Apple’s investment in the UK over the last five years has now surpassed £18 billion, with the technology giant’s engineering teams in the country doubling in that time, the iPhone maker has said. The US tech giant said it now supported 550,000 jobs in the UK through direct employment, its supply chain and the economy around its App Store – with app developers having earned nearly £9 billion since it launched in 2008.
JPMorgan Chase & Co. raised its holdings in Marsh & McLennan Companies, Inc. ( NYSE:MMC – Free Report ) by 4.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,999,771 shares of the financial services provider’s stock after buying an additional 184,239 shares during the quarter. JPMorgan Chase & Co.’s holdings in Marsh & McLennan Companies were worth $892,309,000 at the end of the most recent quarter. A number of other large investors also recently modified their holdings of MMC. Fortitude Family Office LLC grew its position in Marsh & McLennan Companies by 18.8% during the third quarter. Fortitude Family Office LLC now owns 285 shares of the financial services provider’s stock worth $64,000 after buying an additional 45 shares in the last quarter. Kingfisher Capital LLC increased its position in shares of Marsh & McLennan Companies by 4.7% during the second quarter. Kingfisher Capital LLC now owns 1,042 shares of the financial services provider’s stock valued at $220,000 after purchasing an additional 47 shares during the period. Drive Wealth Management LLC raised its stake in shares of Marsh & McLennan Companies by 3.7% in the second quarter. Drive Wealth Management LLC now owns 1,382 shares of the financial services provider’s stock valued at $291,000 after purchasing an additional 49 shares in the last quarter. Legacy Financial Advisors Inc. boosted its stake in Marsh & McLennan Companies by 2.3% during the second quarter. Legacy Financial Advisors Inc. now owns 2,222 shares of the financial services provider’s stock worth $468,000 after buying an additional 49 shares in the last quarter. Finally, Ritholtz Wealth Management lifted its holdings in shares of Marsh & McLennan Companies by 0.6% during the 2nd quarter. Ritholtz Wealth Management now owns 8,953 shares of the financial services provider’s stock worth $1,887,000 after acquiring an additional 51 shares during the period. 87.99% of the stock is currently owned by institutional investors and hedge funds. Analyst Upgrades and Downgrades A number of research analysts have commented on MMC shares. Roth Mkm raised their price target on shares of Marsh & McLennan Companies from $220.00 to $230.00 and gave the stock a “neutral” rating in a research note on Friday, October 18th. Wells Fargo & Company decreased their price target on Marsh & McLennan Companies from $212.00 to $211.00 and set an “equal weight” rating on the stock in a research note on Thursday, October 10th. BMO Capital Markets increased their price objective on Marsh & McLennan Companies from $217.00 to $228.00 and gave the stock a “market perform” rating in a research note on Tuesday, October 22nd. The Goldman Sachs Group set a $220.00 target price on shares of Marsh & McLennan Companies and gave the stock a “sell” rating in a report on Friday, October 18th. Finally, Royal Bank of Canada upgraded shares of Marsh & McLennan Companies from a “sector perform” rating to an “outperform” rating and lifted their target price for the company from $242.00 to $250.00 in a research note on Thursday, December 12th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $228.13. Insider Activity at Marsh & McLennan Companies In other Marsh & McLennan Companies news, Director Oscar Fanjul sold 2,500 shares of the stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $221.55, for a total value of $553,875.00. Following the sale, the director now directly owns 48,549 shares in the company, valued at approximately $10,756,030.95. This trade represents a 4.90 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website . 0.30% of the stock is currently owned by corporate insiders. Marsh & McLennan Companies Price Performance Shares of MMC stock opened at $213.47 on Friday. The firm has a market cap of $104.84 billion, a price-to-earnings ratio of 26.29, a PEG ratio of 2.59 and a beta of 0.94. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.89. Marsh & McLennan Companies, Inc. has a 12 month low of $188.27 and a 12 month high of $235.50. The stock has a 50-day moving average price of $221.60 and a 200 day moving average price of $221.07. Marsh & McLennan Companies ( NYSE:MMC – Get Free Report ) last announced its quarterly earnings data on Thursday, October 17th. The financial services provider reported $1.63 earnings per share for the quarter, beating the consensus estimate of $1.61 by $0.02. The business had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.71 billion. Marsh & McLennan Companies had a net margin of 16.82% and a return on equity of 32.65%. Marsh & McLennan Companies’s revenue was up 5.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.57 earnings per share. Research analysts expect that Marsh & McLennan Companies, Inc. will post 8.68 EPS for the current year. Marsh & McLennan Companies Profile ( Free Report ) Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services. Featured Stories Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. ( NYSE:MMC – Free Report ). Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter .Accounts Payable Automation Market Expected to Reach $17.1 Billion by 2032
Paul Finebaum Puts College Football Playoff Contender on Upset AlertWhy cranberry sauce is America’s least favorite Thanksgiving dish – and 5 creative ways to use itElon Musk backs AfD party in German newspaper opinion piece
- Previous: winph99.com ph
- Next: winph99
